ABSTRACT
Filling injections are the process of implanting various fillers into the dermis. The selection of the correct product according to localization to be injected, the injection technique used, appropriate patient selection and patient expectations, physician experience, joint botulinum toxin injection, laser, chemical peeling affect the cosmetic result in filling process. Although the filling products are quite safe products, various side effects and complications can occur depending on the application made, the place where the filling is made, the product or the application technique. In order to minimize any complications that may arise, the patient’s condition, the filler material to be applied and the technique of application should be assessed in the best possible way, and the users should have theoretical knowledge and application skills at a sufficient level about the products.
References
1Baumann L. Soft tissue augmentation. Turkiye Klinikleri J Cosm Dermatol Special Topics 2003; 4: 186-204.
2Klein AW. Soft tissue augmentation 2006: filler fantasy. Dermatol Ther 2006; 19: 129-133.
3Eken A. Yüz estetiğinde dolgu enjeksiyonları ve uygun dolgu materyalinin seçimi. Turkiye Klinikleri J Med Sci 2008; 28(Suppl): S188-S191.
4Tunca M, Koç E, Kurumlu Z. Yaşlanmış deride dolgu maddeleri; Türkiye Klinikleri Kozmetik Dermatoloji-Özel Konular; 2008; 1.1: 35-39.
5Klein AW, Elson ML. The history of substances for soft tissue augmentation. Dermatol Surg 2000; 26: 1096-1105.
6Frank P, Gendler E. Hyaluronic acid for softtissue augmentation. Clin Plast Surg 2001; 28: 121-126.
7Birol A. Hyaluronic acid derivatives. Turkiye Klinikleri J Int Med Sci 2005; 1: 6-10.
8Sykes JM, Cotofana S, Trevidic P, et al. Upper face: clinical anatomy and regional approacheswith injectable fillers. Plast Reconstr Surg 2015; 136: 204S-218S.
9Kane MAC. Nonsurgical periorbital and brow rejuvenation. Plast Reconstr Surg 2015; 135: 63-71.
10Raspaldo H, Gassia V, Niforos FR, Michaud T. Global, 3-dimensional approach to natural rejuvenation: part I-recommendations for volume restoration and periocular area. J Cosmetic Dermatol 2012; 11: 279-289.
11Sundaram H, Signorini M, Liew S, et al. Global Aesthetics Consensus: botulinum toxin type A-evidence based review, emerging concepts, and consensus recommandations for aestheticuse, including updates oncomplications. Plast Reconstr Surg 2016; 137: 518e-529e.
12Morley AMS, Tban M, Malhotra R, Goldberg RA. Use of hyaluronic acid gel for upper eyelid filling and contouring. Ophtal Plast Reconstr Surg 2009; 25: 440-444.
13Hirmand H. Anatomy and nonsurgical correctionof the tear trough deformity. Plast Reconstr Surg 2010; 125: 699-708.
14Sharad J. Dermal fillers for the treatment oftear trough deformity: a review of anatomy, treatment techniques, and their outcomes. J Cutan Aesthet Surg 2012; 5: 229-238.
15Sattler G, Gout U. Regional applications. Illustratedguide to injectable fillers. 1st ed. NewMalden: Quintessence Publishing; 2016; 123-218. (nette bulamadım.)
16Hwang CJ. Periorbital injectables: understandingand avoiding complications. J Cutan Aesthet Surg 2016; 9: 73-79.
17Hotta TA. Understanding the perioral anatomy. Plast Surg Nurs 2016; 36: 12-18.
18Gassia V, Raspaldo H, Niforos FR, Michaud T. Global 3-dimensional approach to natural rejuvenation: recommendations for perioral, nose, and ear rejuvenation. J Cosmet Dermatol 2013; 12: 123-136.
19Dayan S, Bruce S, Kilmer S, et al. Safety and effectiveness of the hyaluronic acid filler, HYC-24L, for lip and perioral augmentation. Dermatol Surg 2015; 41 Suppl 1: S293-S301.
20Ali MJ, Ende K, Maas CS. Perioral rejuvenation and lip augmentation. Facial Plast Surg Clin North Am 2007; 15: 491-500.
21Jacovella PF. Use of calcium hydroxylapatite (Radiesse) for facial augmentation. Clin Interv Aging 2008; 3: 161-174.
22Mannino GN, Lipner SR. Current concepts in lip augmentation. Cutis 2016; 98: 325-329.
23Ünal İ, Ertam İ. Yüz estetiğinde dolgu maddeleri ve dudak dolgulaması. Turkiye Klinikleri J Cosm Dermatol Special Topics 2009; 2: 44-49.
24Lowe NJ, Maxwell CA, Patnaik R. Adverse reactions to dermal fillers: review. Dermatol Surg 2005; 31: 1616-1625.
25Gladstone HB, Cohen JL. Adverse effects when injecting facial fillers. Semin Cutan Med Surg 2007; 26: 34-39.
26Funt DK. Avoiding malar edema during midface/cheek augmentation with dermal fillers. J Clin Aesthet Dermatol 2011; 4: 32-36.
27Şentürk N. Kozmetik dermatolojide komplikasyon yönetimi. Turkiye Klinikleri J Cosm Dermatol Special Topics 2016; 9: 99-107.
28Christensen LH. Host tissue interaction, fate, and risks of degradable and nondegradablegel fillers. Dermatol Surg 2009; 35 Suppl 2: 1612-1619.
29Monheit GD, Rohrich RJ. The nature of long-term fillers and the risk of complications. Dermatol Surg 2009; 35 Suppl 2: 1598-1604.
30Narins RS, Coleman WP 3rd, Glogau RG. Recommendations and treatment options for nodules and other filler complications. Dermatol Surg 2009; 35 Suppl 2: 1667-1671.
31Dayan SH, Arkins JP, Brindise R. Soft tissue fillers and biofilms. Facial Plast Surg 2011; 27: 23-28.
32Cohen JL. Understanding, avoiding, and managing dermal filler complications. Dermatol Surg 2008; 34: 92-99.
33Cox SE, Lawrance N. Complications of soft tissue fillers. Soft Tissue Augmentation. Ed. Carruthers J, Carruthers A; 2nd Edition. Saunders - Elsevier Inc. Philadelphia, PA, 2008; 151-60.
34Brody HJ. Use of hyaluronidase in thetreatment of granulomatous hyaluronic acid reactions or unwanted hyaluronic acid misplacement. Dermatol Surg 2005; 31(8 Pt 1): 893-897.
35Funt D, Pavicic T. Dermal fillers in aesthetics: an overview of adverse events and treatment approaches. Plast Surg Nurs 2015; 35: 13-32.
36Erbil H, Dincer Rota D. Dolgu uygulamalarında görülen komplikasyonlar ve hasta yönetimi. Turkiye Klinikleri J Cosm Dermatol Special Topics 2017; 10: 71-77.
